Maintenance immunosuppressive therapy and generic cyclosporine A use in adult renal transplantation: A single center analysis

Kidney International

Volumn 77, Issue SUPPL. 115, 2010, Pages

  Diarra, Danielle A ^a   Riegersperger, Markus ^a   Säemann, Marcus D ^a   Sunder Plassmann, Gere ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Conversion; Cyclosporine A; Generic; Immunosuppression; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; EQUORAL; EVEROLIMUS; GENERIC DRUG; LEFLUNOMIDE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOIMMUN; RAPAMYCIN; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; CALCINEURIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; GRAFT RECIPIENT; GYNECOLOGIC INFECTION; HELICOBACTER INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; DRUG ANTAGONISM; METHODOLOGY; MIDDLE AGED;

ADULT; CALCINEURIN; CYCLOSPORINE; DRUGS, GENERIC; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 77951893751     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.505     Document Type: Article

References (9)

1. Säemann MD, Sunder-Plassmann G. Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis. Transpl Immunol 2008; 20: 14-20.
2. Yano I. Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors. Drug Metab Pharmacokinet 2008; 23: 150-157.
3. Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562-2575.
4. Alloway RR, Isaacs R, Lake K et al. Report of the American Society of Transplantation conference on immunosuppressive drugs and the use of generic immunosuppressants. Am J Transplant 2003; 3: 1211-1215.
5. Spasovski G, Masin-Spasovska J, Ivanovski N. Do we have the same clinical results with Neoral and Equoral treatment in kidney transplant recipients? A pilot study. Transpl Int 2008; 21: 392-394.
6. Andrysek T, Masri M, Jegorov A et al. Equoral, new cyclosporine drug delivery system, versus Neoral: a bioequivalence study in healthy volunteers. Transplant Proc 2003; 35: 207-209.
7. Zadrazil J, Jabry SA, Bachleda P et al. Use of EQUORAL in de novo renal transplant recipients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004; 148: 171-173.
8. Masri MA, Haberal M, Rizvi A et al. The pharmacokinetics of Equoral versus Neoral in stable renal transplant patients: a multinational multicenter study. Transplant Proc 2004; 36: 80-83.
9. Perlik F, Masri MA, Rost M et al. Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149: 309-313.